Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21759296 | 0.76 | KDM4E (0.44) | KDM4EALDH1A1HPGDPOLBHSD17B10 | |
| SCHEMBL15128276 | 0.73 | KDM4E (0.53) | KDM4EALDH1A1HPGDGAA | |
| SCHEMBL15128270 | 0.72 | KDM4E (0.34) | KDM4EALDH1A1HPGDGAA | |
| SCHEMBL13698339 | 0.72 | KDM4E (0.44) | KDM4EALDH1A1HPGDPOLBHSD17B10 | |
| SCHEMBL15128273 | 0.71 | KDM4E (0.51) | KDM4EALDH1A1HPGD | |
| SCHEMBL15128256 | 0.69 | KDM4E (0.33) | KDM4EALDH1A1HPGDGAA | |
| SCHEMBL6418003 | 0.69 | ALDH1A1 (0.41) | KDM4EALDH1A1HPGDPOLBHSD17B10 | |
| SCHEMBL14468266 | 0.69 | KDM4E (0.32) | KDM4EALDH1A1POLBGAA | |
| SCHEMBL15128272 | 0.69 | KDM4E (0.36) | KDM4EALDH1A1HPGD | |
| SCHEMBL15128264 | 0.69 | KDM4E (0.33) | KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8318323-B2 | Polycyclic compounds and organic electroluminescence device employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2012-11-27 | — | — | US | disclosed |
| US-8216696-B2 | Quinoxaline derivative, and light emitting element, light emitting device and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20120119196-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2012-05-17 | — | — | US | disclosed |
| US-8049411-B2 | Material for organic electroluminescence device and organic electroluminescence device using the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-11-01 | — | — | US | disclosed |
| US-7768195-B2 | Organic electroluminescent device with improved luminous efficiency | IDEMITSU KOSAN CO., LTD. (JP) | 2010-08-03 | — | — | US | disclosed |
| US-20090309488-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-12-17 | — | — | US | disclosed |
| US-20090174313-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC-ELECTROLUMINESCENCE-MATERIAL-CONTAINING SOLUTION | IDEMITSU KOSAN CO., LTD. (JP) | 2009-07-09 | — | — | US | disclosed |
| US-20090153041-A1 | Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device and Electronic Appliance Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-06-18 | — | — | US | disclosed |
| EP-2067778-A1 | Quinoxaline derivative, and light emitting element, licht emitting device and electronic appliance using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-06-10 | — | — | EP | disclosed |
| US-20070273270-A1 | Organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2007-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090153041-A1 | Quinoxaline Derivative, and Light Emitting Element, Light Emitting Device and Electronic Appliance Using the Same | SLC1A2, SLC18A2, SLC18A3 | KDM4E 258/4885ALDH1A1 1610/4885HPGD 2143/4885 |
| US-20090309488-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | EPCAM, ILK, PPOX | KDM4E 2903/4885ALDH1A1 1810/4885HPGD 2793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.